A handheld device for applying mechanical vibration to a body portion of an individual to treat a condition of the individual, includes: a housing; a cantilever beam having a first portion accommodated in the housing, and a second portion that is moveable relative to the housing, wherein the second portion is configured to apply the mechanical vibration to the body portion; and a motor in the housing, the motor configured to oscillate the second portion of the cantilever beam at an oscillation frequency.

The subject matter of the present disclosure generally relates to techniques for following a treatment protocol having one or more treatment parameters to cause a targeted physiological outcome at a distal site, assessing an expression level of a gene in a region of interest after completing the treatment protocol, and modifying the one or more treatment parameters based on the expression level of the gene. The treatment protocol may include one or more ultrasound energy treatments to the region of interest.

A trigger point treatment system for treating a patient, includes a cart, including a display; a trigger point scanning device with a scanning probe, and a trigger point massage therapy device, including a pressure point tip, a pressure sensor component, and an actual pressure indicator. A method of trigger point treatment includes scanning for myofascial trigger points, including locating, mapping, and marking trigger points; measuring a pressure pain threshold; applying a massage treatment; and optionally applying an injection treatment.

Apparatus and methods for deactivating renal nerves extending along a renal artery of a mammalian subject to treat hypertension and related conditions. An ultrasonic transducer (30) is inserted into the renal artery (10) as, for example, by advancing the distal end of a catheter (18) bearing the transducer into the renal artery. The ultrasonic transducer emits unfocused ultrasound so as to heat tissues throughout a relatively large impact volume (11) as, for example, at least about 0.5 cm.sup.3 encompassing the renal artery to a temperature sufficient to inactivate nerve conduction but insufficient to cause rapid ablation or necrosis of the tissues. The treatment can be performed without locating or focusing on individual renal nerves.

Embodiments of the present disclosure relate to techniques for facilitating personalized neuromodulation treatment protocols. In one embodiment, a predetermined treatment position of an energy application device is used to guide future treatments for the patient. In one embodiment, a position of the energy application device relative to the predetermined treatment position is determined. In one embodiment, a total dose of ultrasound energy applied to the region of interest is determined.

Improved acoustic neurostimulation is provided using two or more acoustic transducers generating an acoustic interference pattern. In a first operating mode the transducers are driven at the same frequency. In a second operating mode the transducers are driven at different frequencies. The acoustic interference pattern is varied electronically by control of the driving frequencies. In addition, a method for neurostimulation excites two confocal ultrasound transducers using an excitation waveform signal that has a time-varying frequency within range containing a resonance frequency of the two transducers, thereby increasing resolution and allowing electronic scanning.

Altering consciousness by transcranial stimulation to adjust the membrane potential duration (FIG. 1, Ref. 7) of sensory cortex dendritic spine necks (FIG. 1, Ref 6); sensory cortex spine neck membranes are conscious.

Embodiments of the invention introduces a method and system for focusing ultrasonic energy through intervening skull tissue into a target site within a target brain tissue region under the skull, includes a transducer emitter array, a transducer receiver array, a processor receiving echo signals from the receiver to determine correction factors for the transducer elements to compensate for refraction occurring due to intervening tissue. The correction factors may include phase correction factors, and the phases of excitation signals provided to the transducer elements may be calibrated focusing based upon the phase correction factors to focus the ultrasonic energy to the tissue at the target site.

A stereotactic frame includes a vertical column that extends up from a base. A first laterally extending support arm extends from a first side of the column and a second laterally extending support arm extends from a second side of the column. One of the first or second support arms may include a transducer assembly. The transducer assembly may move a focal point of the transducer in different lateral and longitudinal horizontal positions and different vertical positions. The transducer assembly also may move the focal point of the transducer beam into different pivoting angled positions. The stereotactic frame applies repeatable ultrasonic energy to targets inside a patient without using invasive attachment procedures and without having to repeatedly use expensive magnetic resonance imaging (MRI) machines.

In an example, physiological signal(s) are received from physiological sensor(s) configured to measure at least one physiological property of a user. An arousal of at least one characteristic of at least one treatment resistant mood disorder is detected through employment of an estimation method based at least in part on at least one of the physiological signal(s). A value for at least one of a plurality of stimulation parameters is selected based at least in part on at least one of the physiological signal(s). An electric field based at least in part on the arousal is produced. The electric field is configured to stimulate at least a portion of a median nerve of the user transcutaneously. The electric field is based at least in part on at least some of the plurality of stimulation parameters.